Page 244 - EJMO-9-3
P. 244

Eurasian Journal of
            Medicine and Oncology                                                 ICU pharmacists and clinical outcomes



               2023;6(8):934-941.                                 studies. J Crit Care. 2015;30(5):1101-1106.
               doi: 10.1002/jac5.1840                             doi: 10.1016/j.jcrc.2015.06.018

            5.   Aljuhani O. The role of critical care pharmacists beyond   15.  Hashimoto M, Asai S, Umezawa K, et al. Impact of ward
               intensive care units: A  narrative review on medication   pharmacist-led antimicrobial stewardship in intensive care
               management for ICU survivors.  Braz J Pharm Sci.   units. J Chemother. 2023;35(3):188-197.
               2022;58:e21012.
                                                                  doi: 10.1080/1120009X.2022.2087652
               doi: 10.1590/s2175-97902022e21012
                                                               16.  Van Den Bergh D, Messina AP, Goff DA, et al. A pharmacist-
            6.   Park TY, Lee SM, Kim SE,  et al. Pharmacotherapeutic   led prospective antibiotic stewardship intervention improves
               problems and pharmacist interventions in a medical   compliance to community-acquired pneumonia guidelines
               intensive care unit. Korean J Crit Care Med. 2015;30(2):82-88.  in 39 public and private hospitals across South Africa. Int J
                                                                  Antimicrob Agents. 2020;56(6):106189.
               doi: 10.4266/kjccm.2015.30.2.82
                                                                  doi: 10.1016/j.ijantimicag.2020.106189
            7.   Agarwal J, Singh V, Das A, Nath SS, Kumar R, Sen M.
               Reversing the trend of antimicrobial resistance in ICU: Role   17.  Nili-Ahmadabadi B, Luisetto M, Nili-Ahmadabadi H,
               of antimicrobial and diagnostic stewardship. Indian J Crit   Nasser H, Mashori GR, Nili-Ahmadabadi M. Clinical
               Care Med. 2021;25(6):635.                          impact of pharmacist presence in ICU medical team on
                                                                  mortality rate. Clin Teamwork. 2016;1:15-33.
               doi: 10.5005/jp-journals-10071-23861
                                                               18.  Alsayed HAH, Sharif-Askari FS, Sharif-Askari NS, Halwani R.
            8.   Esper AM, Martin GS. The impact of comorbid
               [corrected] conditions on critical illness.  Crit Care Med.   Clinical pharmacist interventions in an intensive care unit
               2011;39(12):2728-2735.                             reduces ICU mortality at a tertiary hospital in Dubai, United
                                                                  Arab Emirates. Explor Res Clin Soc Pharm. 2024;14:100431.
               doi: 10.1097/CCM.0b013e318236f27e
                                                                  doi: 10.1016/j.rcsop.2024.100431
            9.   Chiang LH, Huang YL, Tsai TC. Clinical pharmacy
               interventions in intensive care unit patients. J Clin Pharm   19.  Albayrak A, Başgut B, Bıkmaz GA, Karahalil B. Clinical
               Ther. 2021;46(1):128-133.                          pharmacist assessment of drug-related problems among
                                                                  intensive care unit patients in a Turkish university hospital.
               doi: 10.1111/jcpt.13265                            BMC Health Serv Res. 2022;22(1):79.

            10.  Ayhan YE. Role of clinical pharmacists in intensive care unit.      doi: 10.1186/s12913-022-07494-5
               In: The Roles and Responsibilities of Clinical Pharmacists in
               Hospital Settings. Sharjah: Bentham Science Publishers;   20.  Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020
               2024. p. 83-108.                                   statement: An  updated  guideline  for reporting systematic
                                                                  reviews. BMJ. 2021;372:n71.
            11.  Aradhya PJ, Ravi R, Chandra BJ, Ramesh M, Chalasani SH.
               Assessment  of  medication  safety  incidents  associated      doi: 10.1136/bmj.n71
               with high-alert medication use in intensive care setting:   21.  Saaiq M, Ashraf B. Modifying “Pico” question into “Picos”
               A  clinical  pharmacist  approach.  Indian J Crit Care Med.   model for more robust and reproducible presentation of the
               2023;27(12):917-922.                               methodology employed in a scientific study. World J Plast
                                                                  Surg. 2017;6(3):390-392.
               doi: 10.5005/jp-journals-10071-24588
                                                               22.  Collaboration C. RoB 2: A revised Cochrane Risk-of-Bias Tool
            12.  Xu P, Yi Q, Wang C,  et al. Pharmacist-led intervention
               on the inappropriate use of stress ulcer prophylaxis   for Randomized Trials; 2020. Available from: https://www.
               pharmacotherapy in intensive care units: A  systematic   com/bias/resources/rob-2-revised-cochrane-risk-bias-tool-
               review. Front Pharmacol. 2021;12:741724.           randomized-trials [Last accessed on 2019 Dec 06].
                                                               23.  Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring
               doi: 10.3389/fphar.2021.741724
                                                                  inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
            13.  Buckley MS, Roberts RJ, Yerondopoulos MJ, Bushway AK,
               Korkames GC, Kane‐Gill SL. Impact of critical care      doi: 10.1136/bmj.327.7414.557
               pharmacist-led interventions on pain, agitation, and   24.  Gupta A, Das A, Majumder K, et al. Obesity is independently
               delirium in  mechanically ventilated adults: A  systematic   associated with increased risk of hepatocellular cancer-
               review. J Am Coll Clin Pharm. 2023;6(9):1041-1052.  related mortality: A  systematic review and meta-analysis.
                                                                  Am J Clin Oncol. 2018;41(9):874-881.
               doi: 10.1002/jac5.1778
                                                                  doi: 10.1097/COC.0000000000000388
            14.  Wang T, Benedict N, Olsen KM,  et al. Effect of critical
               care pharmacist’s intervention on medication errors:   25.  Leape LL, Cullen DJ, Clapp MD,  et al. Pharmacist
               A  systematic  review  and meta-analysis of  observational   participation on physician rounds and adverse drug events


            Volume 9 Issue 3 (2025)                        236                         doi: 10.36922/EJMO025150116
   239   240   241   242   243   244   245   246   247   248   249